Virtu Financial LLC Cuts Holdings in CVS Health Corporation (NYSE:CVS)

Virtu Financial LLC trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 95.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,147 shares of the pharmacy operator's stock after selling 117,170 shares during the quarter. Virtu Financial LLC's holdings in CVS Health were worth $416,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CVS. Sagespring Wealth Partners LLC purchased a new position in CVS Health in the fourth quarter worth $303,000. Belpointe Asset Management LLC grew its holdings in CVS Health by 2.6% in the fourth quarter. Belpointe Asset Management LLC now owns 9,501 shares of the pharmacy operator's stock worth $426,000 after purchasing an additional 239 shares during the last quarter. MSH Capital Advisors LLC purchased a new position in CVS Health in the fourth quarter worth $218,000. Strategic Investment Solutions Inc. IL grew its holdings in CVS Health by 77.2% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock worth $46,000 after purchasing an additional 446 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its holdings in CVS Health by 3.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 2,115,154 shares of the pharmacy operator's stock worth $94,890,000 after purchasing an additional 69,641 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Bernstein Bank cut their price target on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating on the stock in a report on Wednesday, July 16th. Robert W. Baird upgraded shares of CVS Health from a "neutral" rating to an "outperform" rating and lifted their price objective for the stock from $71.00 to $82.00 in a research note on Thursday. Truist Financial lifted their price objective on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. UBS Group lowered their price objective on shares of CVS Health from $71.00 to $67.00 and set a "neutral" rating for the company in a research note on Tuesday, July 22nd. Finally, Royal Bank Of Canada lifted their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.68.

Insider Buying and Selling at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.22% of the company's stock.

CVS Health Price Performance

NYSE:CVS opened at $66.77 on Friday. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The firm has a market cap of $84.68 billion, a price-to-earnings ratio of 18.65, a PEG ratio of 0.73 and a beta of 0.58. The firm's fifty day moving average is $64.86 and its two-hundred day moving average is $64.54.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company's revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.83 earnings per share. Research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were given a $0.665 dividend. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.0%. CVS Health's dividend payout ratio is 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.